A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
Sponsor
King Faisal Specialist Hospital & Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT00531544
Collaborator
(none)
350
1
64
5.5
Study Details
Study Description
Brief Summary
A SU011248 expanded access protocol for systemic therapy of patients with metastatic Renal Cell Carcinoma who are ineligible for participation in other SU011248 protocols but may derive benefit from treatment with SU011248
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
350 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A SU011248 Expanded Access Protocol for Metastatic RCC Patients Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
Study Start Date
:
Feb 1, 2007
Actual Primary Completion Date
:
Jun 1, 2012
Actual Study Completion Date
:
Jun 1, 2012
Outcome Measures
Primary Outcome Measures
- Efficacy [2001-2012]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients with metastatic Renal Cell Carcinoma who are ineligible for participation in other SU011248 protocols but may derive benefit from treatment with SU011248
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | KFSH&RC | Riyadh | Saudi Arabia | 1211 |
Sponsors and Collaborators
- King Faisal Specialist Hospital & Research Center
Investigators
- Principal Investigator: Shouki Bazarbashi, MD, KFSH&RC, Riyadh, Saudi Arabia
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT00531544
Other Study ID Numbers:
- RAC#2061 043
First Posted:
Sep 19, 2007
Last Update Posted:
Jan 5, 2016
Last Verified:
Jan 1, 2016